STN: BL 125432/0
Proper Name: HPC, Cord Blood
Trade Name: None
Manufacturer: LifeSouth Community Blood Centers, Inc.
- For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment.
June 13, 2013 Approval Letter - HPC Cord Blood BLA 125432
HPC, Cord Blood is an allogeneic cord blood hematopoietic progenitor cell therapy.
Summary Basis for Regulatory Action - HPC, Cord Blood BLA 125432(PDF - 242KB) Approval History, Letters, Reviews, and Related Documents - HPC, Cord Blood BLA 125432
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.